Phase précoce de la leucémie lymphoïde chronique (LLC) et concept de lymphocytose B monoclonale (MBL)

Rapid progress has been achieved recently in the management of CLL. Chemoimmunotherapy including fludarabine, cyclophosphamide and rituximab is now the gold standard in all patients and effective treatments are also available in old patients, particularly those with co-morbidities.